# Photonics Monitoring and Modeling Core

> **NIH NIH U54** · UNIVERSITY OF COLORADO DENVER · 2020 · $793,353

## Abstract

Photonics Monitoring and Modeling Core
Abstract
The Photonics Monitoring and Modeling Core (PMMC) consists of three core photonics
based novel diagnostic technologies and a highly monitored mid-size animal model (rabbit)
testing facility based at the University of California, Irvine, Beckman Laser Institute that
support investigations at UC Irvine, UC San Diego, and the University of Colorado. The Core
will provide all investigators with photonics technologies across all animal models to enable
accurate, precise, quantitative and semi-quantitative, high-resolution imaging and
monitoring capabilities in-vivo. The Core will provide technology and support at the U. C.
Irvine rabbit testing facility, as well as in laboratories at the U. of Colorado for inhalation
injury small animal studies (Drs. White, Veress), and Large Animal Core projects (Dr.
Bebarta), supporting projects 1 (methyl isocyanate), 2 (mustard), 3 (methylmercaptan), and
4 (cyanide). The Core photonics based technologies include: 1) swept-source optical
coherence tomography for real-time, fiber optic, micron resolution, 3-D imaging of airways
for assessment of acute and chronic airway injury for chronic mustard exposure and methyl
isocyanate exposures in rats and pigs (projects 1, 2 and the Large Animal Core), 2) diffuse
optical spectroscopy and continuous wave near infrared spectroscopy for assessment of
effects of the metabolic poisons, cyanide and methylmercaptan, and monitoring of tissue
oxygenation and Cytochrome C oxidase redox states in the rabbit and swine models
(projects 3 and 4), and 3) real-time micro-sensors for continuous tissue lactate monitoring
in animals with metabolic poison exposures (projects 3, 4, and the Large Animal Core). The
core will also provide state-of-the-art rabbit testing facility and established core models for
metabolic agent antidote development supporting projects 3 and 4. Advanced technology
capabilities will be extended to the U. of Colorado as part of the PMMC deliverables, and will
function there in addition to their ongoing availability in the photonics testing facility and
animal operating rooms at UC Irvine Beckman Laser Institute. As shown in our prior
chemical defense research, these core technologies enable more accurate, precise, and
noninvasive determination of injury and treatment effectiveness, dramatically accelerating
antidote development and reducing animal numbers required for definitive results. Thus,
the Core is integrally involved in Projects 1, 2, 3, 4, the Large Animal Core, and in the
overarching structure of this “pipeline from in-vitro, to small animal, to moderate and large
animal” accelerated chemical agent antidote drug development proposal.

## Key facts

- **NIH application ID:** 10003331
- **Project number:** 5U54ES027698-05
- **Recipient organization:** UNIVERSITY OF COLORADO DENVER
- **Principal Investigator:** MATTHEW BRENNER
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $793,353
- **Award type:** 5
- **Project period:** 2016-09-30 → 2022-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10003331

## Citation

> US National Institutes of Health, RePORTER application 10003331, Photonics Monitoring and Modeling Core (5U54ES027698-05). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10003331. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
